The North America Epigenetics Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).
In the context of this research, epigenetics refers to the study of genetic influences that are not wholly encoded by an organism's DNA sequence. Gene expression is the focus of epigenetics. In addition, Epigenetics also refers to functional alterations in the genome that do not involve a change in the nucleotide sequence. DNA methylation, also known as histone modification, is a form of epigenetic process.
Epigenetics is the study of heritable changes in gene function that do not involve changes in DNA sequence, such as chromosomal alterations, and are phenotypic in nature. Heritable alterations can be caused by external causes such as environmental influences or internal factors such as aging, sickness, and others. DNA methylation and histone modification are examples of epigenetics, which modify gene expression without changing the DNA sequence.
Cancer resistance to treatment is a huge stumbling block. Epigenetic medicines, alone or in combination with other treatments, may, nevertheless, be a feasible alternative. The epigenetic medication employed in the lab study renders the tumor vulnerable by preventing cancer cells from hiding from the immune system. As a result, the rising occurrence of cancer is predicted to boost the growth of the epigenetics market.
The rising cancer burden and increased spending on research and development activities are two major growth catalysts for the regional market. According to the American Cancer Society, 1.8 million new instances of cancer will be identified in the United States in 2020, with 606,520 people dying as a result. Cellular responses to apoptosis, cell proliferation, and senescence can all be influenced by epigenetic changes. The market for cardiovascular diseases is expected to increase steadily. Epigenetics has been found to play a key influence in cardiovascular illnesses in recent studies. Epigenetic information can aid in determining an individual's response to a medicine.
Additionally, it can be used to determine the risk factors for cardiovascular illnesses. As a result, it can be used to diagnose and predict cardiovascular illnesses. In the United States, heart disease is one of the major causes of death. According to the Centers for Disease Control and Prevention, one person in America dies from cardiovascular disease every 37 seconds.
The US market dominated the North America Epigenetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $780.8 Million by 2028. The Canada market is anticipated to grow at a CAGR of 16.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 15.6% during (2022 - 2028).
Based on Application, the market is segmented into Oncology and Non-Oncology. Based on Product, the market is segmented into Kits, Reagents, Enzymes, and Instruments. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Epigenetics Market is Estimated to reach $2.9 Billion by 2028, at a CAGR of 14.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abcam plc, Agilent Technologies, Inc., Hologic, Inc., Illumina, Inc., Merck Group, PerkinElmer, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Zymo Research, and Active Motif, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
By Product
- Kits
- Reagents
- Enzymes
- Instruments
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abcam plc
- Agilent Technologies, Inc.
- Hologic, Inc.
- Illumina, Inc.
- Merck Group
- PerkinElmer, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research
- Active Motif, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Epigenetics Market, by Application
1.4.2 North America Epigenetics Market, by Product
1.4.3 North America Epigenetics Market, by End User
1.4.4 North America Epigenetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Dec) Leading Players
Chapter 4. North America Epigenetics Market by Application
4.1 North America Oncology Market by Country
4.2 North America Non Oncology Market by Country
Chapter 5. North America Epigenetics Market by Product
5.1 North America Kits Market by Country
5.2 North America Reagents Market by Country
5.3 North America Enzymes Market by Country
5.4 North America Instruments Market by Country
Chapter 6. North America Epigenetics Market by End User
6.1 North America Pharmaceutical & Biotechnology Companies Market by Country
6.2 North America Academic & Research Institutes Market by Country
6.3 North America Contract Research Organizations Market by Country
Chapter 7. North America Epigenetics Market by Country
7.1 US Epigenetics Market
7.1.1 US Epigenetics Market by Application
7.1.2 US Epigenetics Market by Product
7.1.3 US Epigenetics Market by End User
7.2 Canada Epigenetics Market
7.2.1 Canada Epigenetics Market by Application
7.2.2 Canada Epigenetics Market by Product
7.2.3 Canada Epigenetics Market by End User
7.3 Mexico Epigenetics Market
7.3.1 Mexico Epigenetics Market by Application
7.3.2 Mexico Epigenetics Market by Product
7.3.3 Mexico Epigenetics Market by End User
7.4 Rest of North America Epigenetics Market
7.4.1 Rest of North America Epigenetics Market by Application
7.4.2 Rest of North America Epigenetics Market by Product
7.4.3 Rest of North America Epigenetics Market by End User
Chapter 8. Company Profiles
8.1 Abcam plc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 Hologic, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Merck Group (Merck Millipore)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 Qiagen N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Zymo Research
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Active Motif, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Acquisition and Mergers:
TABLE 1 North America Epigenetics Market, 2018 - 2021, USD Million
TABLE 2 North America Epigenetics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Epigenetics Market
TABLE 4 Product Launches And Product Expansions – Epigenetics Market
TABLE 5 Acquisition and Mergers – Epigenetics Market
TABLE 6 North America Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 7 North America Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 8 North America Oncology Market by Country, 2018 - 2021, USD Million
TABLE 9 North America Oncology Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Non Oncology Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Non Oncology Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 13 North America Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 14 North America Kits Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Kits Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Reagents Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Reagents Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 23 North America Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 24 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 25 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 26 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 27 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 30 North America Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 31 North America Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 32 US Epigenetics Market, 2018 - 2021, USD Million
TABLE 33 US Epigenetics Market, 2022 - 2028, USD Million
TABLE 34 US Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 35 US Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 36 US Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 37 US Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 38 US Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 39 US Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 40 Canada Epigenetics Market, 2018 - 2021, USD Million
TABLE 41 Canada Epigenetics Market, 2022 - 2028, USD Million
TABLE 42 Canada Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 43 Canada Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 44 Canada Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 45 Canada Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 46 Canada Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 47 Canada Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 48 Mexico Epigenetics Market, 2018 - 2021, USD Million
TABLE 49 Mexico Epigenetics Market, 2022 - 2028, USD Million
TABLE 50 Mexico Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 51 Mexico Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 52 Mexico Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 53 Mexico Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 54 Mexico Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 55 Mexico Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 56 Rest of North America Epigenetics Market, 2018 - 2021, USD Million
TABLE 57 Rest of North America Epigenetics Market, 2022 - 2028, USD Million
TABLE 58 Rest of North America Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 59 Rest of North America Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 60 Rest of North America Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 61 Rest of North America Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 62 Rest of North America Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 63 Rest of North America Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 64 key information – Abcam plc
TABLE 65 key Information – Agilent Technologies, Inc.
TABLE 66 Key information – Hologic, Inc.
TABLE 67 key information – Illumina, Inc.
TABLE 68 key Information – Merck GrouP
TABLE 69 key Information – PerkinElmer, Inc.
TABLE 70 Key Information – Qiagen N.V.
TABLE 71 Key Information – Thermo Fisher Scientific, Inc.
TABLE 72 Key Information – Zymo Research
TABLE 73 Key Information – Active Motif, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: PerkinElmer, Inc.
FIG 6 Recent strategies and developments: Active Motif, Inc.